Standard operating procedure

Similar documents
Standard operating procedure

Standard operating procedure

Lead Author Approver Effective Date: 13-MAR-13 Name: Ana Rodriguez Sanchez Review Date: 13-MAR-16

Standard operating procedure

Standard operating procedure

Standard operating procedure

Standard operating procedure

Standard operating procedure

Work instructions. 1. Changes since last revision. 2. Records. 3. Instructions. Documents needed for this WIN

Title: Handling of Art. 29(1) referrals to the CMDh (60 day procedure) by the CMDh secretariat (incl. Article 13 referrals for variations)

All external requests for access to information as well as their responses are entered into the Queries database.

Standard operating procedure

The WIN applies to the Vet Applications team in the Veterinary Regulatory and Organisational Support service (V-VM-ROS).

All the documents related to the EU-RMP Annex 1 activities are stored at the following locations:

Mock-ups checklist - Guidance for checking mock-ups

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) GUIDELINE ON REQUIREMENTS FOR PLASMA MASTER FILE (PMF) CERTIFICATION

Applies to: SA Administrative Assistant, SAWP Scientific Secretary and SA secretarial team in Scientific Advice Section

Standard operating procedure

Guidance for the format and content of the final study report of non-interventional post-authorisation safety studies

European Medicines Agency Standard Operating Procedure

Chapter 5: Extended EudraVigilance Product Report Acknowledgement Message

BEST PRACTICE GUIDE. For Type IB Variations. CMDv/BPG/005 Edition 05. Edition date: 10 April 2015

Cover note on XEVMPD substance controlled vocabulary following the quality control exercise

SUBMISSION OF COMMENTS ON Guideline on Real Time Release Testing (formerly Guideline on Parametric Release) Draft

esubmission Gateway and Web Client Training on the use of XML delivery files for Veterinary submissions

MEDICAL DEVICES REGULATIONS 2002: REGULATIONS 19 and 30 FORM RG2

Pre-notification check for type IB Variations 1

EMA procedural updates

On-boarding of users to SPOR data services

CMD(v)/BPG/006. BEST PRACTICE GUIDE For. Type II Variations. Edition 00. Edition date:

BEST PRACTICE GUIDE for Type IB Variations. CMD(v)/BPG/005. Edition 00. Edition date: Implementation date:

How to send submissions via the Web Client

Multinational assessment teams

3 September

BEST PRACTICE GUIDE for The classification of unforeseen variations

VARIATION FILING PROCEDURE IN EUROPE: A COMPLETE REVIEW

This is the production release of the second iteration of EudraCT 8.1. It includes the following main functional changes:

IRIS Quick guide to the portal for Orphan Industry users

User guide on how to generate PDF versions of the product information - veterinary

European Aviation Safety Agency

Welcome to the portal. We are very pleased for your interest in our vacancies.

Date: May 19, Dear Dr. Domingo,

EUROPEAN MEDICINES AGENCY (EMA) CONSULTATION

ENCePP Code of Conduct Implementation Guidance for Sharing of ENCePP Study Data

Process description for managing duplicates in the context of the Medical Literature Monitoring (MLM) service

EMA esubmission Gateway and Web Client: Questions and answers on Veterinary Applications

MEDICINES CONTROL COUNCIL

esubmissions Web UI Release Notes

COMMISSION IMPLEMENTING DECISION (EU)

EudraVigilance Components & Functionality Introduction

Data Subject Access Request Procedure. Page 1 KubeNet Data Subject Access Request Procedure KN-SOP

Measures for Article 57 Data Quality Assurance

esubmissions Web UI Release Notes

Q&A QP Declaration. Table of contents

GUIDANCE HOW TO IMPLEMENT THE PROJECT VIA THE ELECTRONIC MONITORING SYSTEM (PART I)

Title: Key activities when screening the electronic Reaction Monitoring Reports (ermrs) for new signals

APPROVAL PROCESS TO BE FOLLOWED FOR PROVISIONAL ACCREDITATION OF CBs UNDER FM CERTIFICATION SCHEME

Management of RMP for CAPs in postauthorisation

User Guidance for National Competent Authorities for PSUR Repository

Guidance for registration with EudraVigilance Veterinary

User Guidance for submissions via esubmission Gateway / Web Client using xml delivery files

Administration of PEFC scheme

Guide to Applications for Certificates of Free Sale for Medical Devices

extended EudraVigilance Medicinal Product Dictionary (XEVMPD) Step-by-Step Guide

Guidance for submission and validation of electronic declaration of interests and electronic curriculum vitae

eaf Release Notes The most recent release appears first. Table of Contents Version (Release Date: 04/02/2019)... 7

extended EudraVigilance Medicinal Product Dictionary (XEVMPD) e-learning

PSUR Repository and the EU single assessment

MEDICINES CONTROL COUNCIL

IRIS Quick guide to registration

Citrix Remote Access

Comments received from public consultation on good pharmacovigilance practices (GVP)

esubmission Gateway Web Client

ChromQuest 5.0. Tools to Aid in 21 CFR Part 11 Compliance. Introduction. General Overview. General Considerations

Sparta Systems TrackWise Digital Solution

PMS Iteration 1: analysis of the data efforts & value results and recommendation on the scope

EMA Common Repository: Questions and answers relating to practical and technical aspects of the implementation

QUESTION / CLARIFICATION

QP Current Practices, Challenges and Mysteries. Caitriona Lenagh 16 March 2012

Manual Rabo Corporate Connect

Subject access policy and template response letters

RULES OF TENNESSEE BOARD OF MEDICAL EXAMINERS DIVISION OF HEALTH RELATED BOARDS

CERTIFICATION CONDITIONS

How to Complete a PCR

PSUR Repository Implementation Plan

eaf Release Notes Table of Contents Version (Release Date: 13/07/2018)... 7 Version (Release Date: 16/02/2018)...

OIML-CS PD-05 Edition 2

Outcome of the FMD - IDMP Integration Workshop. 27 th June EMA - London

BOARD OF THE BANK OF LITHUANIA. RESOLUTION No 46 ON THE REGULATIONS ON KEEPING THE PUBLIC REGISTER OF PAYMENT INSTITUTIONS. of 24 December 2009

Standard Operating Procedure. SOP full title: Sponsor processes for reporting Suspected Unexpected Serious Adverse Reactions

Notification to amend firm details

PRESCRIBED FORM TO BE COMPLETED BY A REQUESTER

Issuing Certification Policy

21 CFR PART 11 FREQUENTLY ASKED QUESTIONS (FAQS)

Applying to register as a pharmacist

Mailbox Rental Terms and Conditions

PSUR Repository Interactive Q&A

Vaccine data collection tool Oct Functions, Indicators & Sub-Indicators

Session 4. Workshop on the implementation of ISO standard for ICSRs. Testing with EMA new process

To update firm name and trading names, website address, accounting reference date, auditors, locum, contacts and addresses.

Transcription:

Standard operating procedure Title: of medicinal products Status: PUBLIC Document no.: SOP/INSP/2000 Lead author Approver Effective date: 03-APR-12 Name: Camelia Manta Name: Fergus Sweeney Review date: 03-APR-15 Signature: ON FILE Signature: ON FILE Supersedes: SOP/INSP/2000 (17-OCT-05) SOP/INSP/2002 (01-JUL-03) Date: 29-MAR-12 Date: 29-MAR-12 TrackWise record no.: 1924 1. Purpose Enabling the production of the European Medicines Agency (EMA) certificates of a medicinal product for human and veterinary use in a consistent way. 2. Scope This SOP applies to the Compliance and Inspection Sector. This SOP should be read in conjunction with information, documents and forms made available on the internet. 3. Responsibilities It is the responsibility of each Head of Sector to ensure that this procedure is adhered to within his/her own Sector. The responsibility for the execution of a particular part of this procedure is identified in the right-hand column of section 9. 4. Changes since last revision Extensive revision to the SOP. 5. Documents needed for this SOP All the following templates are available on the EMA website: Home > Regulatory > Human medicines > Post-authorisation > for products > Requesting certificates: Application form for European Medicines Agency certificates of medicinal products. 7 Westferry Circus Canary Wharf London E15 4HB United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7418 8595 E-mail info@ema.europa.eu Website www.ema.europa.eu An agency of the European Union European Medicines Agency, 2012. Reproduction is authorised provided the source is acknowledged.

Statement of quantitative composition. Template for letter from marketing-authorisation holder (MAH) permitting the Agency to send certificates elsewhere than to MAH address. WIN/INSP/2029 Recording, validation and production of certificates of medicinal products. 6. Related documents Information package for certificates of medicinal products issued by the European Medicines Agency: Home > Regulatory > Human medicines > Post-authorisation > for products. European Medicines Agency certificates of medicinal products instructions on how to fill the application form: Home > Regulatory > Human medicines > Post-authorisation > for products > Requesting certificates. Rules of implementation of Council Regulation (EC) No 297/95 on fees payable to the European Medicines Agency and other measures: Home > Regulatory > Human medicines > Fees. Explanatory note on fees payable to the European Medicines Agency: Home > Regulatory > Human medicines > Fees. 7. Definitions Authorisation Information and documents related to a community marketing authorisation, as amended, which is made available by the unit responsible for project management. If product is not authorised, it refers to application. Certificate of medicinal product (CMP) A formal document of the European Medicines Agency produced following this procedure in accordance with the WHO certification scheme for pharmaceutical products moving in international commerce. The certificate provides confirmation from the Agency on the marketing authorisation status and GMP compliance. The full title is certificate of a medicinal product (CMP). The Agency can certify a product only if a valid application for marketing authorisation or for the scientific opinion pursuant to art. 58, has been submitted to the Agency via the centralised procedure. database Fee GMP compliance MA number Master certificate Software used for the recording and production of certificates. It is the amount paid to the European Medicines Agency by companies requesting certificates, in accordance with the Rules for the implementation of Council Regulation (EC) No 297/95 on fees payable to the European Medicines Agency and other measures. Positive outcome of periodic GMP inspection carried out in the manufacturing site producing the pharmaceutical form. Marketing authorisation number, e.g. EU/1/XX/XXX/XXX. Series of entries in the certificates database which are created/updated every time a request for certificates is received. SOP/INSP/2000, 03-APR-12 Page 2/8

PI Request Requester Set SIAMED database Standard procedure Urgent procedure Product Information. A document in standard format (using the template available on the website) that is used by the requester to order certificates from the Agency. Holder of (or applicant for) the community marketing authorisation or any other organisation with the permission of the MAH/MA applicant requesting certificates from the Agency. A maximum of six identical original certificates for a medicinal product with a distinct marketing authorisation number, addressed to the same importing country, issued in the same official language of the European Union and having identical annexes. Model system for computer-assisted drug registration. Procedure for issuing certificates of medicinal products (CMP) within 10 working days, starting on the following working day of receipt of request. Procedure for issuing certificates of medicinal products (CMP) within 2 working days, starting on the following working day of receipt of request. SOP/INSP/2000, 03-APR-12 Page 3/8

8. Process Map(s)/ Flow Chart(s) (numbers refer to the procedure step) START 1. Receipt of request 2. Record request and print reports 3. Validate request 4.2 Contact requester for clarification On hold 4. Validation outcome? Rejected 4.1. Inform requester about reason for rejection yes 4.3 Clarification receipt within 30 working days? Accepted Continue with Step 16 no 5. Master already available? no 5.1 Create new master Continue with step 4.1 yes 6. Update master 7. Date and sign record for request 8. Record sets and print signature page Continue with step 9 SOP/INSP/2000, 03-APR-12 Page 4/8

Proceed from step 8 9. Annexes in the G: drive? no 9.1 Create annexes yes 10. Print masters 11. Print annexes 12. Bind certificates 13. Print letter 14. Errors detected in certificate? yes 14.1 Correct certificate no 15. Ship certificates 16. File request and correspondence END SOP/INSP/2000, 03-APR-12 Page 5/8

9. Procedure Step Action Responsibility 1 Receive CMP request in the certificates mailboxes certificate@ema.europa.eu for the standard procedure and certificate_urgent@ema.europa.eu for the urgent procedure. These mailboxes are checked at least once a day (follow WIN/INSP/2029, step 1). 2 Record request in certificates database. Send e-mail acknowledging receipt of request, start of the procedure and notify the requester about the applicable fee. Print GMP status confirmation and product status report (follow WIN/INSP/2029, steps 1 to 11). 3 Validate request (follow WIN/INSP/2029, step 12). 4 Record validation outcome (follow WIN/INSP/2029, step 12). If the validation outcome is Accepted, proceed with step 5. If the validation outcome is Rejected, proceed with step 4.1. If the validation outcome is On hold, proceed with step 4.2. 4.1 Inform requester about reason for rejection, update validation outcome from On hold to Rejected and proceed with step 16. 4.2 Contact requester by e-mail to ask for clarification. 4.3 Record date in Company contact field in certificates database. If clarification is received within 30 calendar days, proceed with step 3. If no clarification is received within 30 calendar days, proceed with step 4.1. 5 Check in the certificates database whether master certificates for requested presentations are available in the requested languages. If master is not available, proceed with step 5.1. If master is available, proceed with step 6. 5.1 Create new masters for presentations and languages requested. (follow WIN/INSP/2029, steps 13 to 14). Proceed with step 7. 6 Update the master (follow WIN/INSP/2029, steps 13 to 14). SOP/INSP/2000, 03-APR-12 Page 6/8

Step Action Responsibility 7 Date and sign the record for request of certificates. 8 Record sets into certificates database and print out the form certificates of medicinal products for signature according to WIN/INS/2029 (steps 15 to 18). 9 Check if requested annexes are on G: drive (G:/SharedAreas/Certificate/Products). If requested annexes are on the G: drive, proceed with step 10. If annexes need to be created, proceed with step 9.1. 9.1 Create a folder for the requested variation under the product folder on the G: drive. Save the relevant product information from the Agency s external website, and if not updated, from DREAM. From the product information create the requested annexes (follow WIN/INS/2029, steps 19 to 20). Proceed with step 10. 10 Print out master certificates from certificates database (follow WIN/INS/2029, step 21). 11 Print out requested annexes from G: drive (follow WIN/INS/2029, step 22). 12 Bind certificates and corresponding annexes together (follow WIN/INS/2029, step 23). Completion of request for CMP 13 Update certificates database with current date and Days to issue and print out cover letter (follow WIN/INS/2029, step 24-25). Under the standard procedure, certificates are to be sent within 10 working days following receipt of request, not including weekends, bank holidays and periods when the request has to be put on hold, between Company contact date and Reply date. Under the urgent procedure, certificates are to be sent within 2 working days following receipt of request, not including weekends, bank holidays and periods when the request has to be put on hold, between Company contact date and Reply date. 14 Perform quality review (follow WIN/INS/2029, step 26). If errors detected, return to and go to step 14.1. quality review secretary If CMPs are correct proceed with step 15. SOP/INSP/2000, 03-APR-12 Page 7/8

Step Action Responsibility 14.1 Correct certificates and go to step 10. 15 Sign cover letter and prepare shipment of documents (follow WIN/INS/2029, step 27). 16 File request and all related correspondence (follow WIN/INS/2029, step 28). 10. Records Requests for certificates and all the correspondence related to requests for certificates are retained by the Compliance and Inspection sector. Paper copies are filed in the certificates office for three months and after that, archived off site for 10 years. Also electronic records of CMP and annexes are kept in the certificates database and G:drive (G:\SharedAreas\Certificate\Products). SOP/INSP/2000, 03-APR-12 Page 8/8